Abstract
Intravenous resuscitation fluids are administered to critically ill patients primarily to correct symptomatic hypovolaemia. Crystalloids are pragmatic first-line resuscitation fluids for the majority of patients with little evidence that colloids confer any clinical benefit over crystalloids. Fluids should be selected according to the cause and severity of hypovolaemia that vary over the course of acute illness, to prevent toxicity, specifically physiological or organ dysfunction associated with the type of fluid, particularly semi-synthetic colloids and chloride-rich crystalloids, and to minimise excess cumulative fluid balance that is independently associated with adverse outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Foex B. How the cholera epidemic of 1831 resulted in a new technique for fluid resuscitation. Emerg Med J. 2003;20:316–8.
MacGillivray N. Dr. Thomas Latta: the father of intravenous infusion therapy. J Infect Prev. 2009;10:S3–6.
Lee J. Sydney Ringer (1834–1910) and Alexis Hartmann (1898–1964). Anaesthesia. 1981;36:1115–21.
American National Red Cross. History of blood transfusion 2014 (cited 2014 4th April). Available from: http://www.redcrossblood.org/learn-about-blood/history-blood-transfusion
Haase N, Perner A. Hydroxyethyl starch for resuscitation. Curr Opin Crit Care. 2013;19:321–5.
FDA. [cited 2014 17th April]. Available from: www.fda.gov/downloads/biologicsbloodvaccines/newsevents/workshopsmeetingsconferences/ucm325456.ppt
Westphal M, James M, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products-different effects. Anesthesiology. 2009;111:187–202.
Edelman I, Leibman J. Anatomy of body water and electrolytes. Am J Med. 1959;27:256–77.
Starling E. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312–26.
Levick J, Michel C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87:198–210.
Woodcock TM, Woodcock TE. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108:384–94.
Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243–51.
Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235–40.
SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.
Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30:512–8.
SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874–84.
The SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37:86–96.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;10:1412–21.
Myburgh J, McIntyre L. New insights into fluid resuscitation. Intensive Care Med. 2013;39:998–1001.
Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483–95.
Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med. 2013;11:68.
Myburgh J, Finfer S. Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Med. 2013;11:67.
Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911–6.
Myburgh J, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124–34.
Haase N, Wetterslev J, Winkel P, Perner A. Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial. Intensive Care Med. 2013;39:2126–34.
Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;2, CD000567.
FDA. Hydroxyethyl starch solutions: FDA safety communication – boxed warning on increased mortality and severe renal injury and risk of bleeding 2013. Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm358349.htm
MHRA. Press release: MHRA suspends use of hydroxyethyl starch (HES) drips 2013. Available from: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON287028
TGA. Monitoring communication: hydroxyethyl starch (Voluven and Volulyte) and increased risk of mortality 2013. Available from: http://www.tga.gov.au/safety/ews-medicine-hydroxyethyl-starch-130709.htm
Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K. Open letter to the executive director of the European medicines agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth. 2014;112:595–600.
Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med. 2011;39:1335–42.
Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med. 2009;35:1539–47.
Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011;39:2419–24.
Morgan T, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid–base change during acute normovolaemic haemodilution. Intensive Care Med. 2004;30:1432–7.
Handy J, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth. 2008;101:141–50.
Kellum J, Song M, Li J. Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care. 2004;8:331–6.
Kellum J, Song M, Almasri E. Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest. 2006;130:962–7.
Reid F, Lobo D, Williams R, Rowlands B, Allison S. (Ab)normal saline and physiological Hartmann’s solution: a randomized double-blind crossover study. Clin Sci. 2003;104:17–24.
Wilkes N, Woolf R, Mutch M, Mallett S, Peachey T, Stephens R, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid–base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811–6.
Arlati S, Storti E, Pradella V, Bucci L, Vitolo A, Pulici M. Decreased fluid volume to reduce organ damage: a new approach to burn shock resuscitation? A preliminary study. Resuscitation. 2007;72:371–8.
Advanced Trauma Life Support (ATLS) for doctors Chicago. American College of Surgeons Committee on Trauma 2012. Available from: http://www.facs.org/trauma/atls/index.html
Powell-Tuck J, Gosling P, Lobo D, Allison S, Carlson G, Gore M, et al. British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP); 2011. Available from: http://www.bapen.org.uk/pdfs/bapen_pubs/giftasup.pdf
Shaw A, Bagshaw S, Goldstein S, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg. 2012;255:821–9.
Raghunathan K, Shaw A, Nathanson B, StĂ¼rmer T, Brookhart A, Stefan M, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585–91.
The National Heart Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trial Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.
Gustafsson U, Scott M, Schwenk W, Demartines N, Roulin D, Francis N, et al. Guidelines for perioperative care in elective colonic surgery: enhanced recovery after surgery (ERAS(®)) Society recommendations. World J Surg. 2013;37:259–84.
Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W, et al. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2012;2 Suppl 1:S1.
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hammond, N.E., Saxena, M.K., Myburgh, J.A. (2016). Fluid Resuscitation. In: O'Donnell, J., NĂ¡cul, F. (eds) Surgical Intensive Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-19668-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-19668-8_4
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19667-1
Online ISBN: 978-3-319-19668-8
eBook Packages: MedicineMedicine (R0)